Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37

GlobeNewswire April 19, 2018

iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results

GlobeNewswire March 22, 2018

iCAD, Inc. to Host Earnings Call

Accesswire March 22, 2018

iCAD to Report Fourth Quarter and Fiscal 2017 Financial Results on Thursday, March 22, 2018

GlobeNewswire March 16, 2018

iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution

GlobeNewswire March 1, 2018

iCAD Named a Top Artificial Intelligence Medical Imaging Solution Provider by Healthcare Tech Outlook

GlobeNewswire February 8, 2018

Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer

GlobeNewswire December 12, 2017

iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment

GlobeNewswire December 7, 2017

iCAD’s PowerLook® Tomo Detection Experiences Growing Adoption

GlobeNewswire November 27, 2017

iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as “Best of ASTRO 2017”

GlobeNewswire November 9, 2017

iCAD Reports Third Quarter 2017 Financial Results

GlobeNewswire November 8, 2017

iCAD, Inc. to Host Earnings Call

Accesswire November 8, 2017

Imaging for Women Now Offering iCAD’s PowerLook® Tomo Detection for Digital Breast Tomosynthesis

GlobeNewswire November 8, 2017

iCAD to Report Third Quarter 2017 Financial Results on Wednesday, November 8

GlobeNewswire November 1, 2017

iCAD’s PowerLook Tomo Detection for Digital Breast Tomosynthesis Named 2017 Product of the Year by New Hampshire High Technology Council

GlobeNewswire October 26, 2017

iCAD Announces Presentation of New Clinical Data on Xoft System for Treatment of Nonmelanoma Skin Cancer and Early-Stage Breast Cancer at ASTRO 2017

GlobeNewswire September 25, 2017

iCAD to Present at the Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 20, 2017

iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer

GlobeNewswire August 30, 2017

iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million Credit Facility With Silicon Valley Bank

GlobeNewswire August 8, 2017

Investor Network: iCAD, Inc. to Host Earnings Call

Accesswire August 8, 2017